Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required?
- 1 July 1998
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 32 (1) , 169-176
- https://doi.org/10.1016/s0735-1097(98)00189-2
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Risks and Benefits of Antiarrhythmic TherapyNew England Journal of Medicine, 1994
- SotalolNew England Journal of Medicine, 1994
- Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agentsThe American Journal of Cardiology, 1993
- The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillationThe American Journal of Cardiology, 1990
- Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugsJournal of the American College of Cardiology, 1990
- Clinical safety profile of sotalol in patients with arrhythmiasThe American Journal of Cardiology, 1990
- The long QT syndromes: A critical review, new clinical observations and a unifying hypothesisProgress in Cardiovascular Diseases, 1988
- Aggravation of arrhythmia by antiarrhythmic drugs—Incidence and predictorsThe American Journal of Cardiology, 1987
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Quinidine-induced ventricular flutter and fibrillation without digitalis therapyThe American Journal of Cardiology, 1976